Graft Occlusion, Vascular

• 

  Subject Areas on Research

  • A comparison between the HeRO graft and conventional arteriovenous grafts in hemodialysis patients. 
  • A large-scale study of the upper arm basilic transposition for hemodialysis. 
  • A multi-center, dose-escalation study of human type I pancreatic elastase (PRT-201) administered after arteriovenous fistula creation. 
  • A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II Investigators. 
  • ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary intervention. 
  • Activation of vascular smooth muscle cells by TNF and PDGF: overlapping and complementary signal transduction mechanisms. 
  • Acute results, complications, and effect of lesion characteristics on outcome with the solid-state, pulsed-wave, mid-infrared laser angioplasty system: final multicenter registry report. Holmium:YAG Laser Multicenter Investigators. 
  • Acute thrombosis of a composite ascending aortic conduit containing a Bjork-Shiley valve during pregnancy: successful emergency cesarean section and operative repair. 
  • Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous grafts. 
  • An early study on the mechanisms that allow tissue-engineered vascular grafts to resist intimal hyperplasia. 
  • An expanded series of distal bypass using the distal vein patch technique to improve prosthetic graft performance in critical limb ischemia. 
  • Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. 
  • Angiographic changes in vein grafts: stable surrogate or seductive siren? 
  • Antisense to transforming growth factor-beta(1) facilitates the apoptosis of macrophages in rat vein grafts. 
  • Arteriovenous grafts are associated with earlier catheter removal and fewer catheter days in the United States Renal Data System population. 
  • Axillary grafts for difficult hemodialysis access. 
  • Ballooning between a rock and a hard place. 
  • Beta-arrestins regulate atherosclerosis and neointimal hyperplasia by controlling smooth muscle cell proliferation and migration. 
  • Bioengineered hemodialysis access grafts. 
  • Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention. 
  • Bosentan, an endothelin antagonist, augments hepatic graft function by reducing graft circulatory impairment following ischemia/reperfusion injury. 
  • Case 3--1999. Intraoperative coronary thrombosis in association with low-dose aprotinin therapy. 
  • Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. 
  • Clinical correlates of long-term mortality after percutaneous interventions of saphenous vein grafts. 
  • Clinical success, complications and restenosis rates with excimer laser coronary angioplasty. The Percutaneous Excimer Laser Coronary Angioplasty Registry. 
  • Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass. 
  • Combined free tissue transfer and infrainguinal bypass graft: an alternative to major amputation in selected patients. 
  • Combined rotational and directional atherectomy guided by intravascular ultrasound in an occluded vein graft. 
  • Comparison of the efficacy of digital subtraction and film-screen angiography of the lower limb: prospective study in 50 patients. 
  • Coronary artery bypass graft failure after on-pump and off-pump coronary artery bypass: findings from PREVENT IV. 
  • Coronary steal from a left internal mammary artery coronary bypass graft by a left upper extremity arteriovenous hemodialysis fistula. 
  • Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials. 
  • Creation of an Extraluminal Arterial Bypass Graft Using a Commercially Available Self-Expanding Stent Graft: Feasibility Study in a Porcine Model. 
  • Decreased thrombogenicity of vascular prostheses following gas denucleation by hydrostatic pressure. 
  • Delayed stenosis following placement of a polyethylene terephthalate endograft in the cervical carotid artery. Report of three cases. 
  • Design and methodology of the ESPRIT trial: evaluating a novel dosing regimen of eptifibatide in percutaneous coronary intervention. 
  • Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial. 
  • Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial. 
  • Different vascular responses within the same stent detected by optical coherence tomography. 
  • Differential mechanisms of failure of autogenous and non-autogenous bypass conduits: an assessment following successful graft thrombolysis. 
  • Digital intravenous subtraction angiography in the evaluation of reconstructed renal arteries. 
  • Early and late quantitative angiographic results of vein graft lesions treated by excimer laser with adjunctive balloon angioplasty. 
  • Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. 
  • Effect of dipyridamole plus aspirin on hemodialysis graft patency. 
  • Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. EPIC Investigators. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic Complications. 
  • Effectiveness of percutaneous coronary intervention in cardiac allograft vasculopathy. 
  • Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. 
  • Endoscopic harvesting device type and outcomes in patients undergoing coronary artery bypass surgery. 
  • Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. 
  • Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease. 
  • Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial. 
  • Femoral-infrapopliteal bypass with prosthetic grafts. 
  • Forearm versus upper arm grafts for vascular access. 
  • Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial. 
  • Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry. 
  • Gene delivery to aortocoronary saphenous vein grafts in a large animal model of intimal hyperplasia. 
  • Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb? 
  • Genetic variants associated with vein graft stenosis after coronary artery bypass grafting. 
  • Graft vascular disease after cardiac transplantation and its relationship to mean acute rejection score. 
  • Hemodialysis vascular access: effect on urea kinetics and the dialysis prescription. 
  • Human umbilical cord blood-derived endothelial cells reendothelialize vein grafts and prevent thrombosis. 
  • Hypercoagulability affecting early vein graft patency does not exist after off-pump coronary artery bypass. 
  • Hypercoagulable states and antithrombotic strategies in recurrent vascular access site thrombosis. 
  • Identifying patients at risk for premature discontinuation of thienopyridine after coronary stent implantation. 
  • Iloprost in alginate decreases the thrombogenicity of expanded polytetrafluoroethylene. 
  • Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. 
  • Impact of lipid-lowering medications and low-density lipoprotein levels on 1-year clinical outcomes after coronary artery bypass grafting. 
  • Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters. 
  • Implications of early failure of superficial femoral artery endoluminal interventions. 
  • In-Pipeline Stenosis: Incidence, Predictors, and Clinical Outcomes. 
  • In-stent stenosis after stent-assisted coiling: incidence, predictors and clinical outcomes of 435 cases. 
  • Influence of diabetes and perivascular allogeneic endothelial cell implants on arteriovenous fistula remodeling. 
  • Inhibition of vessel allograft rejection by endothelial removal. Morphologic and ultrastructural changes. 
  • Initial nonfunction in cadaveric renal transplantation. 
  • Internal mammary artery graft angioplasty: acute and long-term outcome. 
  • Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. 
  • Late conduit occlusion after modified Fontan procedure with classic Glenn shunt. 
  • Localized delivery of nitric oxide from hydrogels inhibits neointima formation in a rat carotid balloon injury model. 
  • Long-term results of endoscopic versus open saphenous vein harvest for lower extremity bypass. 
  • Management and outcomes of dialysis access-associated steal syndrome. 
  • Management of infrainguinal occluded vein bypasses with a combined approach of thrombolysis and surveillance. A prospective study. 
  • Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. 
  • Measurement of vascular input impedance in infrainguinal vein grafts. 
  • Mechanical versus chemical thrombolysis: an in vitro differentiation of thrombolytic mechanisms. 
  • Microanastomotic response to needle and suture size. 
  • Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts. 
  • Molecular approaches for the treatment of atherosclerosis. 
  • Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study. 
  • Neointimal hyperplasia rapidly reaches steady state in a novel murine vein graft model. 
  • Nitinol intravascular stent: results of preclinical evaluation. 
  • Nitric oxide-producing polyurethanes. 
  • Omega-3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease. 
  • On- versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry [NCDR]). 
  • On-pump versus off-pump coronary-artery bypass surgery. 
  • Outcomes of Saphenous Vein Graft Intervention With and Without Embolic Protection Device: A Comprehensive Review and Meta-Analysis. 
  • Outcomes of prosthetic hemodialysis grafts after deployment of bare metal versus covered stents at the venous anastomosis. 
  • Paradoxical embolus following percutaneous thrombectomy of hemodialysis reliable outflow graft. 
  • Partial and transient relief of conduit obstruction by low-pressure balloon dilation in patients with congenital heart disease. 
  • Patients started on hemodialysis with tunneled dialysis catheter have similar survival after arteriovenous fistula and arteriovenous graft creation. 
  • Percutaneous Coronary Intervention in Native Coronary Arteries Versus Bypass Grafts in Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. 
  • Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry. 
  • Percutaneous interventions on the hemodialysis reliable outflow vascular access device. 
  • Percutaneous revascularization of an extensively diseased saphenous vein bypass graft with a saphenous vein-covered Palmaz stent. 
  • Plasminogen acceleration of urokinase thrombolysis. 
  • Platelet function and pharmacologic inhibition. 
  • Platelet function and total length of intracoronary stents: is there a correlation? 
  • Popliteal artery aneurysms: a 25-year surgical experience. 
  • Popliteal-to-distal bypass: identifying risk factors associated with limb loss and graft failure. 
  • Postintervention Patency Rates and Predictors of Patency after Percutaneous Interventions on Intragraft Stenoses within Failing Prosthetic Arteriovenous Grafts. 
  • Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions. The Percutaneous Excimer Laser Coronary Angioplasty Registry. 
  • Prehospitalization antiplatelet therapy and outcomes after saphenous vein graft intervention. 
  • Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis. 
  • Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. 
  • Prognostic value of thallium-201 single-photon emission computed tomography for patients with multivessel coronary artery disease after revascularization (the Emory Angioplasty versus Surgery Trial [EAST]). 
  • Provisional stenting strategies: systematic overview and implications for clinical decision-making. 
  • Rationale and design of the Drug-Eluting Stents vs Bare-Metal Stents in Saphenous Vein Graft Angioplasty (DIVA) Trial. 
  • Recurrent symptoms following lower extremity arterial bypass surgery. American College of Radiology. ACR Appropriateness Criteria. 
  • Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein grafts. 
  • Regarding "Radial artery deviation and reimplantation inhibits venous juxta-anastomotic stenosis and increases primary patency of radial-cephalic fistulas for hemodialysis". 
  • Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery. 
  • Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery. 
  • Report on the Hemodialysis Reliable Outflow (HeRO) experience in dialysis patients with central venous occlusions. 
  • Resistance to antiplatelet drugs: what progress has been made? 
  • Response to Letters Regarding Article, "Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial". 
  • Response to Letters Regarding Article, "Saphenous Vein Graft Failure After Coronary Artery Bypass Surgery: Insights From PREVENT IV". 
  • Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial. 
  • Risk of distal embolization and infarction with transluminal extraction atherectomy in saphenous vein grafts and native coronary arteries. NACI Investigators. New Approaches to Coronary Interventions. 
  • Safety and clinical effectiveness of drug-eluting stents for saphenous vein graft intervention in older individuals: Results from the medicare-linked National Cardiovascular Data Registry(®) CathPCI Registry(®) (2005-2009). 
  • Salvaging vascular access and treatment of severe limb edema: case reports on the novel use of the hemodialysis reliable outflow vascular access device. 
  • Saphenous vein graft disease: a left main equivalent. 
  • Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV. 
  • Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. 
  • Saphenous vein graft failure and clinical outcomes: toward a surrogate end point in patients following coronary artery bypass surgery? 
  • Simultaneous restenosis of Taxus and Cypher drug-eluting stents. 
  • Single versus multiple internal mammary artery grafting for coronary artery bypass: 15-year follow-up of a clinical practice trial. 
  • Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. 
  • Stenoses in dialysis fistulas: treatment with percutaneous angioplasty. 
  • Stent thrombosis: role of compliance and nonresponsiveness to antiplatelet therapy. 
  • Surgical portosystemic shunts for treatment of portal hypertensive bleeding: outcome and effect on liver function. 
  • Targeting Gbeta gamma signaling in arterial vascular smooth muscle proliferation: a novel strategy to limit restenosis. 
  • Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields. 
  • Technical innovation. Using a covered stent (wallgraft) to treat pseudoaneurysms of dialysis grafts and fistulas. 
  • The bent stent. 
  • The effect of interstitial air on the in vitro thrombogenicity of ePTFE vascular grafts. 
  • The effect of location and configuration on forearm and upper arm hemodialysis arteriovenous grafts. 
  • The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial. 
  • Third universal definition of myocardial infarction. 
  • Thromboembolic Events with Enterprise Versus Pipeline: Porcine In Vivo Experiment. 
  • Thrombolysis in acute peripheral arterial occlusion: predictors of immediate success. 
  • Thrombosed polytetrafluoroethylene hemodialysis fistulas: salvage with combined thrombectomy and angioplasty. 
  • Total pulmonary artery occlusion immediately after lung transplantation: successful revascularization with intravascular stents. 
  • Transcription factor decoy. 
  • Transforming growth factor-beta1 antisense treatment of rat vein grafts reduces the accumulation of collagen and increases the accumulation of h-caldesmon. 
  • Transluminal angioplasty of venous stenoses in polytetrafluoroethylene vascular access grafts. 
  • Transluminal extraction catheter for the treatment of diseased saphenous vein grafts: a multicenter experience. 
  • Transluminal extraction coronary atherectomy. 
  • Treatment of TIPS/biliary fistula-related endotipsitis with a covered stent. 
  • Trends in Bare-Metal Stent Use in the United States in Patients Aged ≥65 Years (from the CathPCI Registry). 
  • Two urokinase dose regimens in native arterial and graft occlusions: initial results of a prospective, randomized clinical trial. 
  • Value and limitation of biplane rest and exercise radionuclide angiography for assessing individual bypass grafts: a prospective study. 
  • Vascular disease in the antiphospholipid syndrome: a comparison with the patient population with atherosclerosis. 
  • Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial. 
• 

  Keywords of People

  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Kim, Charles Yoon, Associate Professor of Radiology, Radiology, Interventional Radiology
  • Middleton, John Paul, Associate Professor of Medicine, Medicine, Nephrology